161 related articles for article (PubMed ID: 30083976)
1. Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker.
Taibi-Djennah Z; Martin-Eauclaire MF; Laraba-Djebari F
Inflamm Res; 2018 Oct; 67(10):863-877. PubMed ID: 30083976
[TBL] [Abstract][Full Text] [Related]
2. Systemic responses following brain injuries and inflammatory process activation induced by a neurotoxin of Androctonus scorpion venom.
Taibi-Djennah Z; Matin-Eauclaire MF; Laraba-Djebari F
Neuroimmunomodulation; 2015; 22(6):347-57. PubMed ID: 25766090
[TBL] [Abstract][Full Text] [Related]
3. Influence of a NH2-terminal extension on the activity of KTX2, a K+ channel blocker purified from Androctonus australis scorpion venom.
Legros C; Feyfant E; Sampieri F; Rochat H; Bougis PE; Martin-Eauclaire MF
FEBS Lett; 1997 Nov; 417(1):123-9. PubMed ID: 9395089
[TBL] [Abstract][Full Text] [Related]
4. The kaliotoxin family enlarged. Purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom.
Laraba-Djebari F; Legros C; Crest M; Céard B; Romi R; Mansuelle P; Jacquet G; van Rietschoten J; Gola M; Rochat H
J Biol Chem; 1994 Dec; 269(52):32835-43. PubMed ID: 7806508
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
6. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
7. Neuropathophysiological effect and immuno-inflammatory response induced by kaliotoxin of androctonus scorpion venom.
Ladjel-Mendil A; Martin-Eauclaire MF; Laraba-Djebari F
Neuroimmunomodulation; 2013; 20(2):99-106. PubMed ID: 23295619
[TBL] [Abstract][Full Text] [Related]
8. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
9. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
[TBL] [Abstract][Full Text] [Related]
10. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
11. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
[TBL] [Abstract][Full Text] [Related]
12. Neuro-Modulation of Immuno-Endocrine Response Induced by Kaliotoxin of Androctonus Scorpion Venom.
Ladjel-Mendil A; Martin-Eauclaire MF; Laraba-Djebari F
J Biochem Mol Toxicol; 2016 Dec; 30(12):580-587. PubMed ID: 27271987
[TBL] [Abstract][Full Text] [Related]
13. Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus.
Srairi-Abid N; Shahbazzadeh D; Chatti I; Mlayah-Bellalouna S; Mejdoub H; Borchani L; Benkhalifa R; Akbari A; El Ayeb M
FEBS J; 2008 Sep; 275(18):4641-50. PubMed ID: 18699777
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
Straub SV; Perez SM; Tan B; Coughlan KA; Trebino CE; Cosgrove P; Buxton JM; Kreeger JM; Jackson VM
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E380-90. PubMed ID: 21586699
[TBL] [Abstract][Full Text] [Related]
15. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
[TBL] [Abstract][Full Text] [Related]
16. C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity.
Kuzmenkov AI; Peigneur S; Chugunov AO; Tabakmakher VM; Efremov RG; Tytgat J; Grishin EV; Vassilevski AA
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):465-472. PubMed ID: 28179135
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and protective effects of interleukin-4 on the neuropathological alterations induced by a potassium channel blocker.
Ahras-Sifi N; Laraba-Djebari F
J Neuroimmunol; 2021 Jun; 355():577549. PubMed ID: 33839521
[TBL] [Abstract][Full Text] [Related]
18. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the first K⁺ channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Martin-Eauclaire MF; Céard B; Belghazi M; Lebrun R; Bougis PE
Toxicon; 2013 Dec; 75():168-76. PubMed ID: 23523531
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
Xie S; Feng J; Yu C; Li Z; Wu Y; Cao Z; Li W; He X; Xiang M; Han S
Peptides; 2012 Jul; 36(1):94-9. PubMed ID: 22580271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
